The Official Website of the Long-Term Investor
Results 31 - 40 of 516 : Previous 1 2 3 4 5 6 7 8 9 Next
Does Pfizer Pass Buffett's Test?
Here's one of Buffett's favorite metrics for evaluating companies.
Will Gilead Sciences Blow It Next Quarter?
Look here for a clue.
Celgene's Management Is Creating Value
What EVA momentum shows us about the folks running Celgene.
Here's How Amgen Is Making You So Much Cash
All cash flow is not created equal.
How Long Does It Take to Make a Buck at Biogen Idec?
Don't just count the cash, time it.
Another generic Lovenox -- oh, my!
Look here for a clue.
Will Biogen Idec Disappoint Analysts Next Quarter?
Look here for a clue.
This Just In: More Upgrades and Downgrades
BMO makes biotech recs.
All Lymphoseek, all the time.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK